©2026 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

Eyewire News: The Podcast
Eyewire Podcast Logo Outlined
Eyewire News: The Podcast

09.30.26

Kodiak Plans to Submit BLA for Zenkuda After Phase 3 Data

Kodiak Sciences meets its primary endpoint in a phase 3 trial for its DME drug candidate clearing the way for a regulatory submission; the European Commission approves Roche’s Susvimo for wet AMD; and Merck announces topline results from a pivotal phase 2b/3 trial evaluating two doses of its DME treatment candidate. Learn more about your ad choices. Visit megaphone.fm/adchoices

View full description +

MORE EPISODES

10.07.26

Special Report: Potential of Robotic Cataract Surgery

09.30.26

Kodiak Plans to Submit BLA for Zenkuda After Phase 3 Data

09.23.26

Breaking News From the ESCRS Congress in London (Part 2 of 2)

09.16.26

Breaking News From the ESCRS Congress in London (Part 1 of 2)

09.09.26

FDA Accepts Nanoscopes's Optogenetic Gene Therapy BLA

09.02.26

FDA Sets PDUFA Date for Investigational Glaucoma Eye Drop

08.26.26

EyePoint Misses Primary Endpoint in Phase 3 Trial But Sees Promise After Analysis

08.12.26

Three Major Acquisitions Announced in Ophthalmology

Show More

Anterior 3D Cataract Cornea General Glaucoma Optometry Pediatric Refractive/LVC Residents & Fellows Retina Retina 3D
close-x